Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-26
2005-07-26
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S334000, C546S088000, C546S258000
Reexamination Certificate
active
06921768
ABSTRACT:
The invention relates to cerium compounds having general formulas (I) Rni+Yin−and (II) Rb+Yb+and their application as medicaments in the prophylaxis and/or treatment of cancer diseases. In formula (I), R is a group of general formula (A):and in formula (II), Rbis a group of general formula (B)
REFERENCES:
F.A. Hart et al., “Lanthanide Complexes-III※Complexes Of 2,2′-Dipyridyl With Lanthanide Chlorides, Thiocyanates, Acetates And Nitrates”,J. Inorg. Nucl. Chem., vol. 27, pp. 1825-1829, (1965).
F.A. Hart et al., “Complexes Of 1,10′-Phenanthroline With Lanthanide Chlorides, Thiocyanates”,J. Inorg. Nucl. Chem., vol. 26, pp. 579-585, (1964).
Akin Gump Strauss Hauer & Feld & LLP
Faustus Forschungs Cie. Translational Cancer Research GmbH
Solola Taofiq
LandOfFree
Cytostatic cerium compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytostatic cerium compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytostatic cerium compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3371061